Literature DB >> 7130900

Antigenic variation of Borrelia hermsii.

H G Stoenner, T Dodd, C Larsen.   

Abstract

At least 24 different serotypes were detected in populations of Borrelia hermsii that originated from a single organism. These serotypes were identified by staining with specific fluoresceinated antisera prepared against cloned populations of living organisms of each type. In the order of decreasing frequency, the 10 types more often encountered were 7, which was clearly dominant, and 2, 17, 24, 13, 2, 1, 21, 11, and 12. Each of the 24 types were shown to change to 7 or more other serotypes. Spirochetemia in mice was persistent, and relapses occurred when the concentration of organisms was sufficient for detection by visual means. After mice were inoculated with a single organism, peak spirochetemia usually occurred on day 4, after which clearance of organisms occurred, and an apparently pure population was replaced by a mixed population consisting of as many as seven variants. These types persisted for 2-3 d before being replaced by other types. Conversions occurred constantly and were independent of relapses. The rate of conversion in mice treated with cyclophosphamide to delay antibody production was comparable to that of controls. Spontaneous conversion was clearly demonstrated in tubes of fortified Kelly's medium inoculated with a single organism of type 7 or 21. 11 different variants appeared in eight cultures of type 21 by the time growth had reached 4 X 10(6)-10(7) organisms/ml. The rate of spontaneous change was estimated to be or approximately 10(-4)-10(-3) per cell per generation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7130900      PMCID: PMC2186838          DOI: 10.1084/jem.156.5.1297

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Stability of fluorescent antibody conjugates stored under various conditions.

Authors:  J H Green; S B Gray; W K Harrell
Journal:  J Clin Microbiol       Date:  1976-01       Impact factor: 5.948

2.  Serologic typing of rickettsiae of the spotted fever group by microimmunofluorescence.

Authors:  R N Philip; E A Casper; W Burgdorfer; R K Gerloff; L E Hughes; E J Bell
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

3.  USE OF MOUSE SERUM IN IDENTIFICATION AND SEROLOGIC CLASSIFICATION OF RICKETTSIA AKARI AND RICKETTSIA AUSTRALIS.

Authors:  E G PICKENS; E J BELL; D B LACKMAN; W BURGDORFER
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

4.  Refinement of fluorescent antibody by gel filtration.

Authors:  M A GMRDON; M R EDWARDS; V N TOMPKINS
Journal:  Proc Soc Exp Biol Med       Date:  1962-01

5.  Rapid fluorescent-antibody conjugation procedure.

Authors:  M Peacock; W Burgdorfer; R A Ormsbee
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

6.  Biology of Borrelia hermsii in Kelly medium.

Authors:  H G Stoenner
Journal:  Appl Microbiol       Date:  1974-10

7.  Outbreak of tick-borne relapsing fever in Spokane County, Washington.

Authors:  R S Thompson; W Burgdorfer; R Russell; B J Francis
Journal:  JAMA       Date:  1969-11-10       Impact factor: 56.272

Review 8.  Symposium on immunosuppressive drugs. Immunosuppressive drugs. I.

Authors:  G W Santos
Journal:  Fed Proc       Date:  1967 May-Jun

9.  Experimental relapsing fever initiated by Borrelia hermsi. II. Sequential appearance of major serotypes in the rat.

Authors:  E M Coffey; W C Eveland
Journal:  J Infect Dis       Date:  1967-02       Impact factor: 5.226

10.  Cultivation of Borrelia hermsi.

Authors:  R Kelly
Journal:  Science       Date:  1971-07-30       Impact factor: 47.728

  10 in total
  126 in total

Review 1.  Genetics of surface antigen expression in Pneumocystis carinii.

Authors:  J R Stringer; S P Keely
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies.

Authors:  A G Barbour; V Bundoc
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Characteristics of Borrelia hermsii infection in human hematopoietic stem cell-engrafted mice mirror those of human relapsing fever.

Authors:  Raja Vuyyuru; Hongqi Liu; Tim Manser; Kishore R Alugupalli
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

4.  The relapsing fever agent Borrelia hermsii has multiple copies of its chromosome and linear plasmids.

Authors:  T Kitten; A G Barbour
Journal:  Genetics       Date:  1992-10       Impact factor: 4.562

Review 5.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

6.  Laboratory confirmation of Lyme disease.

Authors:  T G Schwan; W J Simpson; P A Rosa
Journal:  Can J Infect Dis       Date:  1991

Review 7.  Diversity of the Lyme Disease Spirochetes and its Influence on Immune Responses to Infection and Vaccination.

Authors:  Jerilyn R Izac; Richard T Marconi
Journal:  Vet Clin North Am Small Anim Pract       Date:  2019-04-06       Impact factor: 2.093

8.  Cloning and surface expression in Escherichia coli of a structural gene encoding a surface protein of Haemophilus influenzae type b.

Authors:  P L Holmans; T A Loftus; E J Hansen
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease.

Authors:  L A Magnarelli; J M Meegan; J F Anderson; W A Chappell
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

10.  Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness.

Authors:  J E Craft; D K Fischer; G T Shimamoto; A C Steere
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.